Zubomol SP 100mg/325mg/15mg Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, enhances the anti-inflammatory effect by breaking down inflammatory mediators and promoting the resolution of edema and tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis. Zubomol SP is well-suited for patients requiring rapid and sustained relief from pain and inflammation with improved tissue healing. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. Adverse effects may include gastrointestinal discomfort, allergic reactions, and rarely, hematological abnormalities. Regular monitoring is recommended during prolonged therapy.